Cargando…

Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period

(1) Background: Malignant tumours of the salivary glands have different clinical and histopathological characteristics. They most commonly involve the parotid gland. Histopathologically, the most common are mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (AdCC), acinic cell carcinoma (AcCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Żurek, Michał, Jasak, Kamil, Jaros, Karolina, Daniel, Piotr, Niemczyk, Kazimierz, Rzepakowska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408518/
https://www.ncbi.nlm.nih.gov/pubmed/36011881
http://dx.doi.org/10.3390/ijerph191610247
_version_ 1784774620825518080
author Żurek, Michał
Jasak, Kamil
Jaros, Karolina
Daniel, Piotr
Niemczyk, Kazimierz
Rzepakowska, Anna
author_facet Żurek, Michał
Jasak, Kamil
Jaros, Karolina
Daniel, Piotr
Niemczyk, Kazimierz
Rzepakowska, Anna
author_sort Żurek, Michał
collection PubMed
description (1) Background: Malignant tumours of the salivary glands have different clinical and histopathological characteristics. They most commonly involve the parotid gland. Histopathologically, the most common are mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (AdCC), acinic cell carcinoma (AcCC), adenocarcinoma, carcinoma in pleomorphic adenoma (CPA), and squamous cell carcinoma (SCC). (2) Methods: We analysed 2318 patients with malignant parotid gland tumours reported to the National Cancer Registry (NCR) in Poland over 20 years (1999–2018). The demographic characteristics of patients, clinical factors, and overall survival (OS) were analysed. (3) Results: The average age was 61.33 ± 16.1 years. The majority were males (55%) and urban citizens (64%). High percentage of carcinomas was diagnosed in locoregional (33.7%) and systemic (10.4%) stadium. The most prevalent diagnoses were SCC (33.3%) and adenocarcinoma (19.6%). Surgical resection with adjuvant RT (42.1%) was the most common treatment. The OS analysis showed a median survival time of 5.6 years. The most favorable median OS was found in patients with AcCC (18.30 years), the worst for SCC (1.58 years). (4) Conclusion: AcCC has the best prognosis and SCC the worst. Tumour stadium, treatment, and demographic factors affect prognosis. Improvements in diagnosis and re-evaluation of treatment standards are necessary to enhance the outcome of patients with parotid gland cancers in Poland.
format Online
Article
Text
id pubmed-9408518
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94085182022-08-26 Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period Żurek, Michał Jasak, Kamil Jaros, Karolina Daniel, Piotr Niemczyk, Kazimierz Rzepakowska, Anna Int J Environ Res Public Health Article (1) Background: Malignant tumours of the salivary glands have different clinical and histopathological characteristics. They most commonly involve the parotid gland. Histopathologically, the most common are mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (AdCC), acinic cell carcinoma (AcCC), adenocarcinoma, carcinoma in pleomorphic adenoma (CPA), and squamous cell carcinoma (SCC). (2) Methods: We analysed 2318 patients with malignant parotid gland tumours reported to the National Cancer Registry (NCR) in Poland over 20 years (1999–2018). The demographic characteristics of patients, clinical factors, and overall survival (OS) were analysed. (3) Results: The average age was 61.33 ± 16.1 years. The majority were males (55%) and urban citizens (64%). High percentage of carcinomas was diagnosed in locoregional (33.7%) and systemic (10.4%) stadium. The most prevalent diagnoses were SCC (33.3%) and adenocarcinoma (19.6%). Surgical resection with adjuvant RT (42.1%) was the most common treatment. The OS analysis showed a median survival time of 5.6 years. The most favorable median OS was found in patients with AcCC (18.30 years), the worst for SCC (1.58 years). (4) Conclusion: AcCC has the best prognosis and SCC the worst. Tumour stadium, treatment, and demographic factors affect prognosis. Improvements in diagnosis and re-evaluation of treatment standards are necessary to enhance the outcome of patients with parotid gland cancers in Poland. MDPI 2022-08-18 /pmc/articles/PMC9408518/ /pubmed/36011881 http://dx.doi.org/10.3390/ijerph191610247 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Żurek, Michał
Jasak, Kamil
Jaros, Karolina
Daniel, Piotr
Niemczyk, Kazimierz
Rzepakowska, Anna
Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period
title Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period
title_full Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period
title_fullStr Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period
title_full_unstemmed Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period
title_short Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period
title_sort clinico-epidemiological analysis of most prevalent parotid gland carcinomas in poland over a 20-year period
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408518/
https://www.ncbi.nlm.nih.gov/pubmed/36011881
http://dx.doi.org/10.3390/ijerph191610247
work_keys_str_mv AT zurekmichał clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod
AT jasakkamil clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod
AT jaroskarolina clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod
AT danielpiotr clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod
AT niemczykkazimierz clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod
AT rzepakowskaanna clinicoepidemiologicalanalysisofmostprevalentparotidglandcarcinomasinpolandovera20yearperiod